Leap Therapeutics
LPTX
LPTX
20 hedge funds and large institutions have $23.8M invested in Leap Therapeutics in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 1.7% → 1.8% (+0.1%)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.07M | |
| 2 | +$648K | |
| 3 | +$437K | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$347K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$310K |
Top Sellers
| 1 | -$802K | |
| 2 | -$435K | |
| 3 | -$336K | |
| 4 |
Millennium Management
New York
|
-$105K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.59K |